Status:
COMPLETED
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Fort Belvoir Community Hospital
Neuroscience Research Australia
Conditions:
Mild Traumatic Brain Injury
Vestibular Neuropathy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective for this study is to compare outcome measures from vestibular rehabilitation (VPT) delivered in a traditional method against a new device Incremental Velocity Error (IVE) that improves p...
Eligibility Criteria
Inclusion
- Greater than or equal to 18 years old
- Service members with mTBI and civilian patients with vestibular hypofunction, both of which reports vestibular symptoms (i.e. dizziness, imbalance).
Exclusion
- Any subjects with a self-reported history of significant ophthalmic, neuromuscular, cardiovascular (except hypertension), renal/electrolyte and psychiatric disorders
- Those with uncontrolled severe hypertension (systolic BP of \>200 mm Hg and/or a diastolic BP of \> 110 mmHg at rest)
- Those with a recent history of alcohol and/or drug abuse within the past 6 months
Key Trial Info
Start Date :
October 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT03846830
Start Date
October 11 2021
End Date
April 1 2025
Last Update
November 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21287
2
Fort Belvoir CH
Fort Belvoir, Virginia, United States, 22060